142 related articles for article (PubMed ID: 26328315)
1. Delivery of Transferrin-Conjugated Polysaccharide Nanoparticles in 9L Gliosacoma Cells.
Jeong YI; Kim YW; Jung S; Pei J; Wen M; Li SY; Ryu HH; Lim JC; Jang WY; Kim IY; Moon KS; Jung TY
J Nanosci Nanotechnol; 2015 Jan; 15(1):125-9. PubMed ID: 26328315
[TBL] [Abstract][Full Text] [Related]
2. Preparation of pH-Sensitive Dextran Nanoparticle for Doxorubicin Delivery.
Wang B; Liu P; Shi B; Gao J; Gong P
J Nanosci Nanotechnol; 2015 Apr; 15(4):2613-8. PubMed ID: 26353472
[TBL] [Abstract][Full Text] [Related]
3. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.
Jeong YI; Jin SG; Kim IY; Pei J; Wen M; Jung TY; Moon KS; Jung S
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):149-55. PubMed ID: 20427160
[TBL] [Abstract][Full Text] [Related]
5. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
8. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy.
Agrawal P; Singh RP; Sonali ; Kumari L; Sharma G; Koch B; Rajesh CV; Mehata AK; Singh S; Pandey BL; Muthu MS
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():167-176. PubMed ID: 28254282
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
10. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
11. Nano-Aggregates of Doxorubicin-Conjugated Methoxy Poly(ethylene glycol)-b-Carboxymethyl Dextran Copolymer.
Lee SJ; Kang MS; Oh JS; Jeong YI; Park IK; Lee HC
J Nanosci Nanotechnol; 2015 Aug; 15(8):5566-70. PubMed ID: 26369118
[TBL] [Abstract][Full Text] [Related]
12. Fattigation-platform nanoparticles using apo-transferrin stearic acid as a core for receptor-oriented cancer targeting.
Amin HH; Meghani NM; Park C; Nguyen VH; Tran TT; Tran PH; Lee BJ
Colloids Surf B Biointerfaces; 2017 Nov; 159():571-579. PubMed ID: 28854413
[TBL] [Abstract][Full Text] [Related]
13. Preparation, drug release and cellular uptake of doxorubicin-loaded dextran-b-poly(ɛ-caprolactone) nanoparticles.
Li B; Wang Q; Wang X; Wang C; Jiang X
Carbohydr Polym; 2013 Apr; 93(2):430-7. PubMed ID: 23499079
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
15. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
Zhu B; Zhang H; Yu L
Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
[TBL] [Abstract][Full Text] [Related]
16. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
18. Dextran-based doxorubicin nanocarriers with improved tumor penetration.
Sagnella SM; Duong H; MacMillan A; Boyer C; Whan R; McCarroll JA; Davis TP; Kavallaris M
Biomacromolecules; 2014 Jan; 15(1):262-75. PubMed ID: 24313925
[TBL] [Abstract][Full Text] [Related]
19. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
[TBL] [Abstract][Full Text] [Related]
20. Self-Organized Nanoparticles of Caffeic Acid Conjugated Polysaccharide and Its Anticancer Activity.
Lee SJ; Choi KC; Kang MS; Oh JS; Jeong YI; Lee HC
J Nanosci Nanotechnol; 2015 Feb; 15(2):1130-4. PubMed ID: 26353622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]